Archives of Pharmacal Research

, Volume 39, Issue 10, pp 1382–1390 | Cite as

Novel hybrids of drug with bioactive heterocycles for enhancing biological activity

  • Parthiban ValentinaEmail author
  • Kaliappan Ilango
  • Muthu K. Kathiravan
Research Article


A novel series of aceclofenac hybridised with 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazoles were designed using molecular hybridization approach and synthesised 6aj. The structural integrity was confirmed by analytical methods. The hybrid molecules were subjected to in vitro cytotoxic studies against four human cancer cell lines PA‐1, OAW‐42, T47-D and MCF‐7 by MTT assay method. The results indicate that the hybrid molecules bearing halogen on phenyl ring in 6th position of triazolo-thiadiazole exhibited significant cytotoxic activity. The test compounds were also screened for antifungal activity against two strains.


Triazolo-thiadiazole Cytotoxic Molecular hybrids 



The authors greatly acknowledge their thanks to Dr K. S. Lakshmi, Dean, College of Pharmacy, S.R.M University, Chennai for providing the facilities to carry out this work.


  1. Allen LB, Huffmann JH, Sidwall RW, Antimicro AG (1973) 1-β-DRibofuranosyl-[1,2,4]-triazolo-3-carboxamide (Virazole-ICN 1229) to stimulate interferon. Chemother 3:534–535Google Scholar
  2. Balaban AT, Oniciu DC, Katritzky AR (2004) Aromaticity as a cornerstone of heterocyclic chemistry. Chem Rev 104:2777–2812CrossRefPubMedGoogle Scholar
  3. Block JH, Beale JM (2004) Wilson and Gisvold’s text book of organic medicinal and pharmaceutical chemistry. Lippincott Williams and Wilkins, Philadelphia, p 276Google Scholar
  4. Chowrasia D, Karthikeyana C, Chourea L, Sahabjada Gupta M, Arshad Md, Trivedi P (2013) Synthesis, characterization and anti cancer activity of some fluorinated 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles. Arab J Chem. doi: 10.1016/j.arabjc.2013.08.026 Google Scholar
  5. Conklin KA (2000) Dietary antioxidants during cancer chemotherapy, impact on chemotherapeutic effectiveness and development of side effects. Nutr Cancer 37:1–18CrossRefPubMedGoogle Scholar
  6. Conklin KA (2002) Dietary polyunsaturated fatty acids impact on cancer, chemotherapy and radiation. Altern Med Rev 7:4–21PubMedGoogle Scholar
  7. Dmitry A, Douglas CNJ (2007) Synthesis and reactivity of 4-(2-chloro-5-nitrophenyl)-1, 2, 3-thiadiazole. A novel one pot synthesis of N-substituted-indole-2-thiols. Org Chem 72:5368–5373CrossRefGoogle Scholar
  8. El-Khawass SM, Khall MA, Hazza AA, Bassiouny HA, Loutfy NF (1989) Synthesis of some 1,2,4-triazol-[3,4-b]-1,3,4-thiadiazole as potent anthelmentics. Farmaco 44:703PubMedGoogle Scholar
  9. Goswami BN, Kattaky JCS, Baruah NJ (1984) Synthesis and Antibacterial activity of 1-(2,4-dichlorobenzoyl)-4-substituted thiosemicarbazides, 1,2,4-triazole and their methyl derivatives. Heterocycl Chem 21:1225–1229CrossRefGoogle Scholar
  10. Gottfried E, Lang SA, Renner K, Bosserhoff A, Gronwald W, Rehli M, Einhell S, Gedig I, Singer K, Seilbeck A, Mackensen A, Grauer O, Hau P, Dettmer K, Andreesen R, Oefner PJ, Kreutz M (2013) New aspects of an old drug-diclofenac targets MYC and glucose metabolism in tumor cells. PLoS One. doi: 10.1371/journal.pone.0066987 Google Scholar
  11. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L (1996) Effects of nonsteroidal anti- inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol 52:237–245CrossRefPubMedGoogle Scholar
  12. Hart C (1999) Drugs for Migraine in Modern Drug Discovery. Am Chem Soc 2:20–31Google Scholar
  13. Haydar Y, Sevgi K, Murat K, Ozgun Y, Ummuhan O, Esra S (2006) Synthesis and antioxidant activities of some 4-benzylidenamino-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives. J Org Chem 45:715–718Google Scholar
  14. Hill DL (1980) Thiadiazoles for the treatment of cancer or neurological disease. Cancer Chemother Pharmacol 4:215–220PubMedGoogle Scholar
  15. Holla BS, Poojary KN, Rao BS, Shivananda MK (2002) New bis-aminomercaptotriazoles and bis-triazolothiadiazoles as possible anticancer agents. Eur J Med Chem 37(6):511–517CrossRefPubMedGoogle Scholar
  16. Ilango K, Valentina P (2010) Facile synthesis and cytotoxic activity of 3,6 - disubstituted-1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole. Eur J Chem 1(1):50–53CrossRefGoogle Scholar
  17. Ilango K, Valentina P, Vivek G (2009) Synthesis and antimicrobial activity of 2, 5- disubstituted -1, 3, 4-oxadiazole derivatives. Asian J Chem 21(9):6915–6919Google Scholar
  18. Ilango K, Valentina P, Kumar G, Dixit D, Nilewar S, Kathiravan MK (2015) Design, synthesis and QSAR studies on a series of 2,5-disubstituted 1,3,4-oxadiazole derivatives of diclofenac and naproxen for analgesic and anti-inflammatory activity. Med Chem 11(8):753–763CrossRefPubMedGoogle Scholar
  19. Imtiaz KSZ, Aliya I, Nasim HR, Jim SJI (2014) Synthesis, crystal structure and biologicalevaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4- triazolo[3,4-b]-1,3,4-thiadiazines. Eur J Med Chem 78:167–177CrossRefGoogle Scholar
  20. Invidiata FP, Simoni D, Scintu F, Finna F (1996) 3, 6-Disubstituted-1,2,4-triazolo-[3,4-b]-thiadiazole: synthesis, antimicro bial and antiviral activity. Farmaco 51:659–664PubMedGoogle Scholar
  21. Kakwani MD, Suryavanshi P, Ray M, Rajan MG, Majee S, Samad A, Devarajan P, Degani MS (2011) Design, synthesis and antimycobacterial activity of cinnamide derivatives: a molecular hybridization approach. Bioorg Med Chem Lett 21(7):1997–1999CrossRefPubMedGoogle Scholar
  22. Khan RH, Srivastava RAK, Rastogi RC (1978) Synthesis of new 5-substituted-4-phenyl-3-aryloxymethyl phenyl ethyl-1,2,4-triazoles and their antimicrobial activity. Indian J Pharm Sciences 49:48–51Google Scholar
  23. Lamson DW, Brignall MS (1999) Antioxidants in cancer therapy, their actions and interactions with oncologic therapies. Altern Med Rev 4:304–329PubMedGoogle Scholar
  24. Lesy R, Olena V, Serhiy H, Lucyusz Z, Andrzej G (2007) New 5-substituted thiazolo-[3,2-b][1,2,4]-triazol-6-one: synthesis and anticancer evaluation. Eur J Med Chem 42:641–648CrossRefGoogle Scholar
  25. Liu T, Dong XW, Xue N, Wu R, He QJ, Yang B, Hua YZ (2009) Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives. Bioorg Med Chem 17:6279–6285CrossRefPubMedGoogle Scholar
  26. Matao K (1957) Synthesis of related compounds of thiosemicarbazide-s-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives. Pharm Bull 5:385–389CrossRefGoogle Scholar
  27. Nelson JA, Rose LM, Benette L (1977) Mechanism of action of 2-amino-1, 3, 4-thiadiazole. Cancer Res 37:182–187PubMedGoogle Scholar
  28. Odlo K, Hentzen J, Chabert JF, Ducki S, Gani AB, Sylte I, Skrede M, Flenes VA, Hansen TV (2008) 1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin. Bioorg Med Chem 16:4829–4840CrossRefPubMedGoogle Scholar
  29. Omar AM, Abolwaya OM (1986) Synthesis and invitro antimicrobial and antifungal properties of some novel 1,3,4-thiadiazole and s-triazole-[3, 4-b]-1, 3, 4-thiadiazole derivatives. J Heterocycl Chem 23:1339–1341CrossRefGoogle Scholar
  30. Pei LZ, An ND, Min Z, Hai KY, Wen WY, Shu GW (2012) Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety. Bioorg Med Chem Lett 22:4471–4474CrossRefGoogle Scholar
  31. Priyabrata P, Rajesh S, Prasanta KS (2008) Synthesis andevaluation of 2-amino-5-sulfanyl-1,3,4-thiadiazoles as antidepressant, anxiolytic and anticonvulsant agent. Med Chem Res 18:351–361Google Scholar
  32. Richard WY, Kathryn H, Joyce AE, James RV, George WA (1956) 1, 3, 4-Thiadiazole and thiadiazoline sulfonamides as carbonic anhydrase inhibitors. synthesis and structural studies. J Am Chem Soc 78:4646–4649CrossRefGoogle Scholar
  33. Schenone S, Brullo O, Bondavalli F, Ranise A, Fillippelli W, Rinaldi B, Capuano A, Falcone G (2006) New 1,3,4-thiadiazole derivatives endowed with analgesic and antiinflammatory activities. Bioorg Med Chem 14:1698–1705CrossRefPubMedGoogle Scholar
  34. Siddiq N, Alam MS (2009) Progress report on biological activities of thiadiazoles. Res. Asia 6:261–264Google Scholar
  35. Sunil D, Isloor AM, Shetty P, Satyamoorthy K, Bharath Prasad AS (2010) 6-[3-(4-Fluorophenyl)-1H-pyrazol-4-yl]-3-[(2-naphthyloxy)methyl][1,2,4]triazolo[3,4-b][1,3,4]thiadiazole as a potent antioxidant and an anticancer agent induces growth inhibition followed by apoptosis in HepG2 cells. Arab J Chem 3(4):211–217CrossRefGoogle Scholar
  36. Tsukamoto K, Suno M, Igarashi K, Kozai Y, Sugino L (1975) Mechanism of action of 2,2′-methylene diimino-bis-1,3,4-thiadiazole as an antitumor agent. Cancer Res 37:2631–2636Google Scholar
  37. Viegas-Junior C, Danuello A, da Silva Bolzani V, Barreiro EJ, Fraga CA (2007) Molecular hybridization: a useful tool in the design of new drug prototypes. Curr Med Chem 14(17):1829–1852CrossRefPubMedGoogle Scholar
  38. Zhou H, Liu W, Su Y, Wei Z, Liu J (2010) NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling. Cancer Cell 17:560–573CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Pharmaceutical Society of Korea 2016

Authors and Affiliations

  • Parthiban Valentina
    • 1
    Email author
  • Kaliappan Ilango
    • 2
  • Muthu K. Kathiravan
    • 2
  1. 1.Department of Pharmaceutical ChemistryJaya College of Paramedical Sciences, College of PharmacyChennaiIndia
  2. 2.Department of Pharmaceutical Chemistry, SRM College of PharmacySRM UniversityKancheepuramIndia

Personalised recommendations